Atlas Trials

Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.

Clinical trial NCT01726920 · WITHDRAWN

Trial details

NCT number
NCT01726920
Sponsor
Ache Laboratorios Farmaceuticos S.A.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
MigraineHeadache
Start date
2014-07-01
Primary completion
2014-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.